Skip to content

Microcirculatory Perfusion in Patients With Coma After Out-of-hospital Cardiac Arrest

Microcirculatory Perfusion as Measured by Sublingual SDF Imaging and NIRS in Patients With Coma After Out-of-hospital Cardiac Arrest Treated With Mild Therapeutic Hypothermia (TH) or Not Treated With Mild-TH

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01850485
Enrollment
22
Registered
2013-05-09
Start date
2012-02-29
Completion date
2013-05-31
Last updated
2015-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest

Keywords

cardiac arrest, therapeutic hypothermia, microcirculation

Brief summary

The hypothesis is: In patients after an out of hospital cardiac arrest, treated with therapeutic hypothermia (33°C) will be found significantly more microcirculatory abnormalities, compared to the same group of patients treated with 36°C.

Detailed description

The purpose of this study is to investigate the (sublingual) microcirculation in patients after an out of hospital cardiac arrest (OHCA). The microcirculation is measured in this study by Sublingual Side Stream Darkfield (SDF) Imaging and Near InfraRed Spectroscopy (NIRS) at admission and after 12 and 24 hours.

Interventions

DEVICEmicrocirculation by SDF and NIRS, in 33 and 36 degrees

at baseline, after 12 and 24 hours in both arms

Sponsors

Frisius Medisch Centrum
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* out-of-hospital cardiac arrest * \> 18 years * informed consent * ROSC (return of spontaneous circulation) \< 4 hours

Exclusion criteria

* recent maxillofacial surgery * participation in other clinical trials

Design outcomes

Primary

MeasureTime frameDescription
Microvascular Flow Index (MFI)baseline measurementMicrovascular Flow Index; minimum score = 0 (= no flow) and maximum score = 3 (=normal flow)

Secondary

MeasureTime frameDescription
Fluid Balance After 24 Hours24 hours
Inotropes and Vasopressor Dosebaseline
RincStO2baselinetissue oxygenation measured by Near Infrared Spectroscopy
Lactate24 hourslactate levels in serum
SvO224 hours(venous oxygen saturation)
Cardiac Index24 hoursCardiac Index is cardiac output indexed for body weight

Countries

Netherlands

Participant flow

Participants by arm

ArmCount
Normothermia, 36 Degrees
microcirculation after cardiac arrest by SDF and NIRS, in patients treated with 36 degrees microcirculation by SDF and NIRS, in 33 and 36 degrees: at baseline, after 12 and 24 hours in both arms
9
33 Degrees, Therapeutic Hypothermia
microcirculation after cardiac arrest by SDF and NIRS, in patients treated with 33 degrees microcirculation by SDF and NIRS, in 33 and 36 degrees: at baseline, after 12 and 24 hours in both arms
13
Total22

Baseline characteristics

CharacteristicNormothermia, 36 Degrees33 Degrees, Therapeutic HypothermiaTotal
Age, Continuous64.3 years
STANDARD_DEVIATION 12.4
68.9 years
STANDARD_DEVIATION 9.3
66.6 years
STANDARD_DEVIATION 9.9
Region of Enrollment
Netherlands
9 participants13 participants22 participants
Sex: Female, Male
Female
3 Participants1 Participants4 Participants
Sex: Female, Male
Male
6 Participants12 Participants18 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 90 / 13
serious
Total, serious adverse events
0 / 90 / 13

Outcome results

Primary

Microvascular Flow Index (MFI)

Microvascular Flow Index; minimum score = 0 (= no flow) and maximum score = 3 (=normal flow)

Time frame: baseline measurement

ArmMeasureValue (MEDIAN)
Normothermia, 36 DegreesMicrovascular Flow Index (MFI)1.7 units on a scale
33 Degrees, Therapeutic HypothermiaMicrovascular Flow Index (MFI)1.1 units on a scale
Secondary

Cardiac Index

Cardiac Index is cardiac output indexed for body weight

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Normothermia, 36 DegreesCardiac Index2.1 L/m2Standard Deviation 0.64
33 Degrees, Therapeutic HypothermiaCardiac Index1.9 L/m2Standard Deviation 0.73
Secondary

Fluid Balance After 24 Hours

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Normothermia, 36 DegreesFluid Balance After 24 Hours1.79 litersStandard Deviation 0.92
33 Degrees, Therapeutic HypothermiaFluid Balance After 24 Hours3.33 litersStandard Deviation 1.18
Secondary

Inotropes and Vasopressor Dose

Time frame: baseline

ArmMeasureValue (MEDIAN)
Normothermia, 36 DegreesInotropes and Vasopressor Dose0.00 mcg/kg/min
33 Degrees, Therapeutic HypothermiaInotropes and Vasopressor Dose0.00 mcg/kg/min
Secondary

Lactate

lactate levels in serum

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Normothermia, 36 DegreesLactate1.71 mmol/lStandard Deviation 0.48
33 Degrees, Therapeutic HypothermiaLactate2.78 mmol/lStandard Deviation 1.1
Secondary

RincStO2

tissue oxygenation measured by Near Infrared Spectroscopy

Time frame: baseline

ArmMeasureValue (MEAN)Dispersion
Normothermia, 36 DegreesRincStO244.6 percent saturationStandard Deviation 15.8
33 Degrees, Therapeutic HypothermiaRincStO258.9 percent saturationStandard Deviation 13.5
Secondary

SvO2

(venous oxygen saturation)

Time frame: 24 hours

ArmMeasureValue (MEAN)Dispersion
Normothermia, 36 DegreesSvO261.2 percent saturationStandard Deviation 13.6
33 Degrees, Therapeutic HypothermiaSvO269.4 percent saturationStandard Deviation 10.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026